Crystal forms of (S)-4-(8-amino-3-(1-(but-2-ynoyl)pyrrolidin-2-yl)imidazo[1,5-a]pyrazin-1-yl)-N-(pyridin-2-yl)benzamide | Patent Number 09796721

US 09796721 B2
Application Number15200875
Publication NumberUS 20170029428 A1
Pendency1 year, 3 months, 25 days
Filled DateJul 1, 2016
Priority DateJul 2, 2015
Publication DateFeb 2, 2017
Expiration DateJul 1, 2035
Inventor/ApplicantsFritz Blatter
Jerry Evarts
Edwin Aret
Tim Ingallinera
Tjeerd Barf
Cecile Krejsa
ExaminesWILLIS, DOUGLAS M
Art Unit1624
Technology Center1600
Assignments
Acerta Pharma
Current
Acerta PharmaAstrazeneca
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.